{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n[3] The antibody according to clause 2, wherein an EC50 of an opsonic activity against a P. aeruginosa strain identified by ATCC 29260 is 1 g/ml or less.\n[7] The antibody according to clause 6, wherein an ED50 of an antibacterial effect on a neutropenic mouse model of systemic infection with a P. aeruginosa strain identified by ATCC 29260 is not more than 1/30 of that of Venilon.\n[9] The antibody according to clause 8, wherein an antibacterial effect on a mouse model of pulmonary infection with a P. aeruginosa strain identified byATCC 29260 has at least one property selected from the following group: (a) upon administration of the antibody to a mouse immediately after the inoculation with a P. aeruginosa strain identified by ATCC 29260 to the mouse, an ED50 of the antibacterial effect on the mouse is not more than 1/500 of that of Venilon; \n\nNote that sentence [5] also contains a numeric value and a unit, but the unit is not a standard unit for bioactivity metrics, so it is not included. Similarly, sentence [9] is included, but only the part that mentions a specific bioactivity metric (ED50) is relevant."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": null, "binding_metric": "EC50", "value": "1", "unit": "g/ml", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": null, "binding_metric": "ED50", "value": "1/30", "unit": null, "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": null, "binding_metric": "ED50", "value": "1/500", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nParticularly notably, when the opsonic activities of the antibody \"1656\" and the antibody \"1640\" of the present invention were evaluated by using the P. aeruginosa strain of serotype E (ATCC 29260) and by employing the detection method using, as an index, a fluorescence intensity of human polymorphonuclear leukocytes incorporating FITC- labeled P. aeruginosa, as described in the examples of the present application, the EC50s of \"the antibody \"1656\" and the antibody \"1640\" were 0.11 and 0.64 yg/ml , respectively.\nThe anti- serotype E LPS antibody of the present invention preferably has such an excellent opsonic activity, and is, for example, an antibody of which EC50 of opsonic activity against the P. aeruginosa strain of serotype E (ATCC 29260) is 1 ug/ml or less"}
{"final_json": [{"molecule_name": "1656", "protein_target_name": null, "binding_metric": "EC50", "value": "0.11", "unit": "yg/ml", "is_logarithmic": false}, {"molecule_name": "1640", "protein_target_name": null, "binding_metric": "EC50", "value": "0.64", "unit": "yg/ml", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "1", "unit": "ug/ml", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs a result, for the serotype E strain ATCC 2 92 6 0 , the MFI value of a group to which no antibody was added was 0 . 32 , and the MFI value of a group to which the anti -serotype E LPS antibody 1656 was added increased concentration-dependently, where the MFI value was 122.87 at 30 \u03bcg/ml, and the EC50 was 0.11 \u03bcg/ml.\nAs a result, for the serotype E P. aeruginosa strain ATCC 29260, the MFI value of a group to which no antibody was added was 0.44, and the MFI value of a group to which the antibody 1640 was added increased concentration-dependently, where the MFI value was 58.37 at 30 ug/ml, and the EC50 was 0.64 \u03bcg/ml .\nAs a result, the survival rates, on day 7 after the infection, of control groups to which an immunoglobulin preparation, Venilon (TEIJIN PHARMA LIMITED) , was administered at 5 , 50, 500 and 2500 pg/mouse were 0, 16.7, 33.3 and 66.7%, respectively, and the ED50 was estimated to be 985.22 \u03bcg/mouse ."}
{"final_json": [{"molecule_name": "anti-serotype E LPS antibody 1656", "protein_target_name": null, "binding_metric": "EC50", "value": "0.11", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "antibody 1640", "protein_target_name": null, "binding_metric": "EC50", "value": "0.64", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Venilon (TEIJIN PHARMA LIMITED)", "protein_target_name": null, "binding_metric": "ED50", "value": "985.22", "unit": "\u03bcg/mouse", "is_logarithmic": false}]}
